Double-blind randomized controlled pilot study of the efficacy and tolerability of pirlindole, a reversible inhibitor of monoamine oxidase A, and mianserin, in the treatment of depression

Human Psychopharmacology

Volumn 12, Issue 1, 1997, Pages 41-46

  De Wilde, J ^a   Mertens, C ^a   Van Dorpe, J ^b   Bruhwyler, J ^c   Geczy J ^c  

^a Neuro Psychiat Kliniek St Camillus   (Belgium)

^b AZ Heilig Hart   (Belgium)

^c Therabel Pharma Belgium   (Belgium)

Author keywords

antidepressant; depression; mianserin; pirlindole; reversible inhibitor of monoamine oxidase A (RIMA)

Indexed keywords

MIANSERIN; PIRLINDOLE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; XEROSTOMIA;

EID: 0031039207     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(199701/02)12:1<41::AID-HUP829>3.0.CO;2-7     Document Type: Article

References (28)

1. Amrein, R., Hetzel, W., Stahl, M. and Schmid-Burgk, W. (1993). RIMA - a new concept in the treatment of depression with moclobemide. International. Journal of Clinical Psychopharmacology, 7, 123-132.
2. Bakish, D., Bradwejn, J., Nair, N., McClure, J., Remick, R. and Bulger, L. (1992). A comparison of moclobemide, amitriptyline and placebo in depression: a Canadian multicentre study. Psychopharmacology, 106, S98-S101.
3. Blaha, L. (1983). A double-blind comparative study of pirlindole and amitriptyline in thirty depressive patients. In: Psychiatry. The State of the Art. Vol 3. Pharmacopsychiatry, Pichot, P., Berner, P., Wolf, R. and Thau, K. (Eds), Plenum Press, New York, pp. 303-309.
4. Bougerol, T., Uchida, C., Gachoud, J. P., Köhler, M. and Mikkelsen, H. (1992). Efficacy and tolerability of moclobemide compared with fluvoxamine in depressive disorder (DSM III). A French/Swiss double-blind trial. Psychopharmacology, 106, S102-S108.
5. Cassachia, M., Carolei, A., Barba, C., Frontoni, M., Rossi, A., Meco, G. and Zylberman, M. R. (1984). A placebo-controlled study of the antidepressant activity of moclobemide, a new MAO-A inhibitor. Pharmacopsychiatry, 17, 122-125.
6. Chen, D. T. and Ruch, R. (1993). Safety of moclobemide in clinical use. Clinical Neuropharmacology, 17, S50-S57.
7. Danish University Antidepressant Group (1986). Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicentre study. Psychopharmacology, 90, 131-138.
8. Da Prada, M., Cesura, A. M., Kettler, R., Zürcher, G. and Haefely, W. (1985). Conversion of the neurotoxic precursor 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine into its pyridinium metabolite by human platelet monoamine oxidase type B. Neuroscience Letters, 57, 257-262.
9. Davis, J. M. (1985). Antidepressant drugs. In: Comprehensive Textbook of Psychiatry, Vol 4, Kaplan, H. L. and Sadock, B. J. (Eds), Williams and Wilkins; Baltimore, pp. 1513-1537.
10. De Wilde, J. E., Geerts, S., Van Dorpe, J., Bruhwyler, J. and Géczy, J. (1996). A double-blind randomized placebo-controlled study of the efficacy and safety of pirlindole, a reversible monoamine oxidase inhibitor, in the treatment of depression. Act Psychiatrica Scandinavica, in press.
11. Fitton, A., Faulds, D. and Goa, K. L. (1992). Moclobemide: A review of its pharmacological properties and therapeutic use in depressive illness. Drugs, 43, 561-596.
12. Guelfi, J. D., Payan, C., Fermanian, J., Pedarriosse, A. M. and Manfredi, R. (1992). Moclobemide versus clomipramine in endogenous depression. A double-blind randomized clinical trial. British Journal of Psychiatry, 160, 519-524.
13. Kettler, R., Da Prada, M. and Burkard, W. P. (1990). Comparison of monamine oxidase-A inhibition by moclobemide in vitro and ex vitro in rats. Acta Psychiatrica Scandinavica, 82, 101-102.
14. Laux, G., Classen, W., Sofic, E., Becker, T., Riederer, P., Lesch, K. P., Struck, M. and Beckmann, H. (1990). Clinical, biochemical and psychometric findings with the new MAO-A-inhibitors moclobemide and brofaromine in patients with major depressive disorder. Journal of Neural Transmission, 32, 189-195.
15. Lehmann, E., Kinzler, E., Stuckmann, A. and Hahlhege, M. (1983). A double-blind comparative study on the use of 225 mg pirlindole and 150 mg desipramine in the treatment of depressive in-patients. In: Psychiatry. The State of the Art. Vol 3. Pharmacopsychiatry, Pichot, P., Berner, P., Wolf, R. and Thau, K. (Eds), Plenum Press, New York, pp. 321-327.
16. Lonnqvist, J., Sintonen, H., Syvälahti, E., Appelberg, B., Koskinen, T., Mannikko, T., Mehtonen, O. P., Naarala, M., Sihvo, S., Auvinen, J. and Pitkanen, H. (1994). Antidepressant efficacy and quality of life in depression: a double-blind study with moclobemide and fluoxetine. Acya Psychiatrica Scandinavica, 89, 363-369.
17. Maj, J., Michaluk, J., Rawlow, A., Rogoz, Z. and Skuza, G. (1986). Central action of the antidepressant drug pirlindole. Arzneimittel Forschung Drug Research, 36, 1198-1201.
18. Martorana, P. A. and Nitz, R. E. (1979). The new antidepressant pirlindole: a comparison with imipramine and tranylcypromine. Arzneimittel Forschung Drug Research, 29, 946-949.
19. Mashkovsky, M. D. and Andrejeva, N. I. (1981). Pharmacological properties of 2,3,3a,4,5,6-hexahydro-8-methyl-1H-pyrazino [3,2,1-j,k] carbazol hydrochloride (Pirlindole), a new antidepressant. Arzneimittel Forschung Drug Research, 31, 75-79.
20. McGrath, P. J., Stewart, J. W. and Harrinson, W. (1986). Phenelzine treatment of melancholia. Journal of Clinical Psychiatry, 47, 420-422.
21. Pöldinger, W. (1983). Pirlindole: results of an open clinical study in out-patients and of a double-blind study against maprotiline. In: Psychiatry. The State of the Art. Vol 3. Pharmacopsychiatry, Pichot, P., Berner, P., Wolf, R. and Thau, K. (Eds), Plenum Press, New York, pp. 283-289.
22. Renfordt, E. (1983). A comparison of pirlindole and amitriptyline in a double-blind controlled study. In: Psychiatry. The State of the Art. Vol 3. Pharmacopsychiatry, Pichot, P., Berner, P., Wolf, R. and Thau, K. (Eds), Plenum Press, New York, pp. 311-317.
23. Reynaert, C., Parent, M., Mirel, J., Janne, P. and Haazen, L. (1995). Moclobemide versus fluoxetine for a major depressive episode. Psychopharmacology, 118, 183-187.
24. Saletu, B., Grünberger, J., Rajna, P., Linzmayer, L. and Simhandl, C. (1983). Examining pharmaco EEG-based predictions about the antidepressant action of pirlindole by double-blind clinical trials. In: Psychiatry. The State of the Art. Vol 3. Pharmacopsychiatry. Pichot, P., Berner, P., Wolf, R. and Thau, K. (Eds), Plenum Press, New York, pp. 291-296.
25. Schäpperle, O., Eckmann, F. and Immich, H. (1983). A double-blind comparison of pirlindole with amitriptyline and imipramine. In: Psychiatry. The State of the Art. Vol 3. Pharmacopsychiatry, Pichot, P., Berner, P., Wolf, R. and Thau, K. (Eds), Plenum Press, New York, pp. 297-302.
26. Schraven, V. E. and Reibert, R. (1984). Hemmung der Monoaminoxidase A und B in Herz und Gehirn von Ratten durch Amitriptylin, Pargylin und Pirlindol. Arzneimittel Forschung Drug Research, 34, 1258-1260.
27. Tanghe, A., Geerts, S., Van Dorpe, J., Brichard, B., Bruhwyler, J. and Géczy, J. Double-blind randomized controlled study of the efficacy and tolerability of two reversible monoamine oxidase A inhibitors, pirlindole and moclobemide, in the treatment of depression. Acta Psychiatrica Scandinavica, submitted for publication.
28. Versiani, M., Oggero, U., Alterwain, P., Capponi, R., Dajas, F., Heinze-Martin, G., Marquez, C. A., Poleo, M. A., Rivero-Almanzor, L. E., Rossel, L., Schmid-Burgk, W. and Udabe, U. (1989). A double-blind comparative trial of moclobemide v. imipramine and placebo in major depressive episodes. British Journal of Psychiatry, 155, 72-77.